Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011;18(17):2655-60.
doi: 10.2174/092986711795933722.

Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease

Barbara Borroni  1 , Chiara Agosti, Enrico Magnani, Monica Di Luca, Alessandro Padovani
Affiliations
Review

Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease

Barbara Borroni et al. Curr Med Chem. 2011.

Abstract

Progressive Supranuclear Palsy (PSP) is a progressive neurodegenerative syndrome characterized by supranuclear palsy, postural instability, and mild dementia. Neuropathologically, PSP is a four-repeat tauopathy, defined by the accumulation of neurofibrillary tangles and tufted astrocytes. Etiology remains elusive, but genetic background has a key-role in the disease pathogenesis. Recent studies have reported high familial aggregation in PSP patients, and it has been widely demonstrated that Microtuble Associated Protein Tau (MAPT) gene mutations are causative of monogenic autosomal dominant PSP. In sporadic cases, genetic advances have further confirmed the role of MAPT in increasing disease risk, and the H1 MAPT haplotype has been consistently associated with PSP, while the H2 haplotype seems protective. Conversely, no major environmental risk factors have been reported so far. A proper evaluation of known susceptibility factors related to PSP pathogenesis may help in defining neuroprotective therapeutic approaches.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways.
    Jang Y, Thuraisamy T, Redding-Ochoa J, Pletnikova O, Troncoso JC, Rosenthal LS, Dawson TM, Pantelyat AY, Na CH. Jang Y, et al. Clin Transl Med. 2022 Nov;12(11):e1076. doi: 10.1002/ctm2.1076. Clin Transl Med. 2022. PMID: 36354133 Free PMC article.
  • Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives.
    Przewodowska D, Marzec W, Madetko N. Przewodowska D, et al. Front Mol Neurosci. 2021 Aug 26;14:720220. doi: 10.3389/fnmol.2021.720220. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34512258 Free PMC article. Review.
  • Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis.
    Zhao Y, Tseng IC, Heyser CJ, Rockenstein E, Mante M, Adame A, Zheng Q, Huang T, Wang X, Arslan PE, Chakrabarty P, Wu C, Bu G, Mobley WC, Zhang YW, St George-Hyslop P, Masliah E, Fraser P, Xu H. Zhao Y, et al. Neuron. 2015 Sep 2;87(5):963-75. doi: 10.1016/j.neuron.2015.08.020. Neuron. 2015. PMID: 26335643 Free PMC article.
  • Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, Butzow R, Campbell IG, Chang-Claude J, Chen K, Cook LS, Cramer DW, deFazio A, Dennis J, Doherty JA, Dörk T, Eccles DM, Edwards DV, Fasching PA, Fortner RT, Gayther SA, Giles GG, Glasspool RM, Goode EL, Goodman MT, Gronwald J, Harris HR, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Kar SP, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Koushik A, Lambrechts D, Le ND, Levine DA, Massuger LF, Matsuo K, May T, McNeish IA, Menon U, Modugno F, Monteiro AN, Moorman PG, Moysich KB, Ness RB, Nevanlinna H, Olsson H, Onland-Moret NC, Park SK, Paul J, Pearce CL, Pejovic T, Phelan CM, Pike MC, Ramus SJ, Riboli E, Rodriguez-Antona C, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Shan K, Siddiqui N, Sieh W, Stampfer MJ, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Tworoger SS, Tyrer JP, Webb PM, Wentzensen N, White E, Willett WC, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J. Yang Y, et al. Cancer Res. 2019 Feb 1;79(3):505-517. doi: 10.1158/0008-5472.CAN-18-2726. Epub 2018 Dec 17. Cancer Res. 2019. PMID: 30559148 Free PMC article.
  • Regulation of human MAPT gene expression.
    Caillet-Boudin ML, Buée L, Sergeant N, Lefebvre B. Caillet-Boudin ML, et al. Mol Neurodegener. 2015 Jul 14;10:28. doi: 10.1186/s13024-015-0025-8. Mol Neurodegener. 2015. PMID: 26170022 Free PMC article. Review.
See all "Cited by" articles

Publication types